Qingrui Huang
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 9
- Viral gastroenteritis research and epidemiology 4
- COVID-19 Clinical Research Studies 4
- Virology top 10%
- Obstetrics and Gynecology top 10%
- Pregnancy and preeclampsia studies 2
-
- Virology and Viral Diseases 2
- Liver Disease Diagnosis and Treatment 2
-
- Immunotherapy and Immune Responses 5
-
- Virus-based gene therapy research 2
- Journals
- Nature Communications (2 papers)SHILAP Revista de lepidopterología (1 paper)Nature Immunology (1 paper)
In The Last Decade
Qingrui Huang
22 papers receiving 503 citations
Peers
Comparison fields: 5 of 71
- Infectious Diseases 246
- Virology 44
- Obstetrics and Gynecology 50
- Hepatology 40
- Epidemiology 154
Countries citing papers authored by Qingrui Huang
This map shows the geographic impact of Qingrui Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingrui Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingrui Huang more than expected).
Fields of papers citing papers by Qingrui Huang
This network shows the impact of papers produced by Qingrui Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingrui Huang. The network helps show where Qingrui Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qingrui Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 45 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 7 | |
| 8 | 2022 | 18 | |
| 9 | 2021 | 56 | |
| 10 | 2021 | 30 | |
| 11 | 2021 | 3 | |
| 12 | 2021 | 9 | |
| 13 | 2021 | 58 | |
| 14 | 2021 | 11 | |
| 15 | 2021 | 2 | |
| 16 | 2018 | 57 | |
| 17 | 2015 | 46 | |
| 18 | 2014 | 19 | |
| 19 | 2013 | 37 | |
| 20 | 2013 | 33 |
About Qingrui Huang
Qingrui Huang is a scholar working on Infectious Diseases, Virology and Obstetrics and Gynecology, having authored 23 papers that have together received 514 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (9 papers), Immunotherapy and Immune Responses (5 papers), Viral gastroenteritis research and epidemiology (4 papers), COVID-19 Clinical Research Studies (4 papers), Virus-based gene therapy research (2 papers), Pregnancy and preeclampsia studies (2 papers), Virology and Viral Diseases (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Infectious Diseases (246 citations), Virology (44 citations) and Obstetrics and Gynecology (50 citations). Qingrui Huang has collaborated with scholars based in China, Czechia and Canada. Frequent co-authors include Jinghua Yan, Jiawei Zeng, Tao Hu, Weili Yu, Mei Zhong, George F. Gao, Qihui Wang, Fengze Wang, F. Li and Siyu Tian. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Nature Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.